CMND — Clearmind Medicine Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapSucker Stock
- CA$4.30m
- -CA$0.35m
Annual balance sheet for Clearmind Medicine, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2018 October 31st | 2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.074 | 0.001 | 0.33 | 4.6 | 0.44 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.008 | 0.003 | 0.003 | 0.161 | 0.134 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.082 | 0.004 | 0.333 | 4.92 | 0.593 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.165 | 0.175 | 0.18 | 0.021 | 0.066 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.247 | 0.178 | 0.513 | 5.16 | 1.13 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.008 | 0.045 | 0.013 | 0.357 | 2.59 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.008 | 0.045 | 0.013 | 0.357 | 2.64 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.239 | 0.134 | 0.499 | 4.8 | -1.51 |
| Total Liabilities & Shareholders' Equity | 0.247 | 0.178 | 0.513 | 5.16 | 1.13 |
| Total Common Shares Outstanding |